Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BNC-210 by Bionomics for Social Anxiety Disorder (SAD/Social Phobia): Likelihood of Approval
BNC-210 is under clinical development by Bionomics and currently in Phase III for Social Anxiety Disorder (SAD/Social Phobia). According to...
Data Insights
BNC-210 by Bionomics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
BNC-210 is under clinical development by Bionomics and currently in Phase II for Post-Traumatic Stress Disorder (PTSD). According to GlobalData,...